PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressor

Octavian Bucur(Beth Israel Deaconess Medical Center), Roya Khosravi-Far(Beth Israel Deaconess Medical Center)

Discoveries

June 30, 2014

10.15190/d.2014.8

Cited by 26

Related Papers

A novel caspase 8 selective small molecule potentiates TRAIL-induced cell death

|Scientific Reports|2015|28

Combination of Bortezomib and Mitotic Inhibitors Down-Modulate Bcr-Abl and Efficiently Eliminates Tyrosine-Kinase Inhibitor Sensitive and Resistant Bcr-Abl-Positive Leukemic Cells

|PLoS ONE|2013|24

Shedding light on DNA methylation and its clinical implications: the impact of long-read-based nanopore technology

|Epigenetics & Chromatin|2024|16